Home > Laboratory > Diagnostic Tests > Infectious Disease Tests >

Care-Start SARS-CoV-2 Rapid Antigen Test (20 Tests) (COVID TESTING) (CLIA Waived)
CareStart SARS-CoV-2 Rapid Antigen Test (20 Tests) (COVID-19 TESTING) (CLIA Waived)


 
Our Price: $299.00

Product Code: RCLM02572

  
Details
 

US-made intended point-of-care (POC) test results in minutes.

Due to the highly contagious nature and global health crises, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical. Particularly, the identification of subclinical or asymptomatic cases is important to reduce or stop the infection because these individuals may transmit the virus.

Features and Benefits

  • Lateral flow assay
  • No equipment required
  • Rapid results at 10 minutes
  • Minimally invasive specimen collection (nasopharyngeal swabs)
  • Intended at POC setting (i.e., in patient care settings) by medical professionals
  • Detect SARS-CoV-2 nucleocapsid protein antigen with ultra high performance
  • Identify acute infection with 88.4% sensitivity and 100% specificity
  • CLIA waived rapid antigen


Specimen Collection and Handling



Test Procedure Steps



Result Interpretation


Materials Included

  • 20 Test Devices
  • 20 Assay Buffer
  • 20 Extraction Vials and Caps
  • 20 Specimen Collection Swabs
  • 1 Positive and 1 Negative Control Swabs
  • 1 Instructions of Use

CPT Code

  • 87811 (SARS antigen visually read)
  • National average reimbursement: $41/test
Documentation
Testing Guide

Share your knowledge of this product with other customers... Be the first to write a review

Browse for more products in the same category as this item:

Laboratory > Diagnostic Tests > Infectious Disease Tests